- Home
- Publications
- Publication Search
- Publication Details
Title
Regulation of PP2A by Sphingolipid Metabolism and Signaling
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 4, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2015-01-15
DOI
10.3389/fonc.2014.00388
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ser70 phosphorylation of Bcl-2 by selective tyrosine nitration of PP2A-B56 stabilizes its antiapoptotic activity
- (2014) I. C. C. Low et al. BLOOD
- FTY720 Induces Apoptosis of M2 Subtype Acute Myeloid Leukemia Cells by Targeting Sphingolipid Metabolism and Increasing Endogenous Ceramide Levels
- (2014) Limin Chen et al. PLoS One
- Expression and prognostic significance of CIP2A in cutaneous malignant melanoma
- (2013) Feng Shi et al. BIOMARKERS
- Antagonistic activities of the immunomodulator and PP2A-activating drug FTY720 (Fingolimod, Gilenya) in Jak2-driven hematologic malignancies
- (2013) J. J. Oaks et al. BLOOD
- Targeting inhibitor 2 of protein phosphatase 2A as a therapeutic strategy for prostate cancer treatment
- (2013) Archana Mukhopadhyay et al. CANCER BIOLOGY & THERAPY
- CIP2A expression and prognostic role in patients with esophageal adenocarcinoma
- (2013) Tuomo Rantanen et al. MEDICAL ONCOLOGY
- Clinical implications of CIP2A protein expression in breast cancer
- (2013) Guangzhe Yu et al. MEDICAL ONCOLOGY
- Expression and biological role of CIP2A in human astrocytoma
- (2013) FUXIN YI et al. Molecular Medicine Reports
- Ser9 phosphorylation causes cytoplasmic detention of I2PP2A/SET in Alzheimer disease
- (2013) Guang Yu et al. NEUROBIOLOGY OF AGING
- Over-Expression of Cancerous Inhibitor of PP2A (CIP2A) in Bone Marrow Cells from Patients with a Group of High-Risk Myelodysplastic Syndromes
- (2013) Na Li et al. PATHOLOGY & ONCOLOGY RESEARCH
- CIP2A Influences Survival in Colon Cancer and Is Critical for Maintaining Myc Expression
- (2013) Armin Wiegering et al. PLoS One
- CIP2A is overexpressed in osteosarcoma and regulates cell proliferation and invasion
- (2013) Mo Zhai et al. TUMOR BIOLOGY
- CIP2A expression is associated with altered expression of epithelial–mesenchymal transition markers and predictive of poor prognosis in pancreatic ductal adenocarcinoma
- (2013) Lei Wang et al. TUMOR BIOLOGY
- Sphingosine-1-Phosphate Links Persistent STAT3 Activation, Chronic Intestinal Inflammation, and Development of Colitis-Associated Cancer
- (2012) Jie Liang et al. CANCER CELL
- Sphingosine analogue drug FTY720 targets I2PP2A/SET and mediates lung tumour suppression via activation of PP2A-RIPK1-dependent necroptosis
- (2012) Sahar A. Saddoughi et al. EMBO Molecular Medicine
- H3K27 methylation and H3S28 phosphorylation-dependent transcriptional regulation by INHAT subunit SET/TAF-Iβ
- (2012) Ji-Young Kim et al. FEBS LETTERS
- Identification and characterization of protein phosphatase 2C activation by ceramide
- (2012) David M. Perry et al. JOURNAL OF LIPID RESEARCH
- Phosphorylation of SET Protein at Ser171 by Protein Kinase D2 Diminishes Its Inhibitory Effect on Protein Phosphatase 2A
- (2012) Atsushi Irie et al. PLoS One
- SET oncoprotein overexpression in B-cell chronic lymphocytic leukemia and non-Hodgkin lymphoma: a predictor of aggressive disease and a new treatment target
- (2011) D. J. Christensen et al. BLOOD
- Cancerous inhibitor of PP2A (CIP2A) at diagnosis of chronic myeloid leukemia is a critical determinant of disease progression
- (2011) C. M. Lucas et al. BLOOD
- Sphingolipids in cancer
- (2011) Hideki Furuya et al. CANCER AND METASTASIS REVIEWS
- Mechanism of inhibition of PP2A activity and abnormal hyperphosphorylation of tau by I2PP2A/SET
- (2011) Lisette Arnaud et al. FEBS LETTERS
- Inhibition of Protein Phosphatase 2A Activity by PI3Kγ Regulates β-Adrenergic Receptor Function
- (2011) Neelakantan T. Vasudevan et al. MOLECULAR CELL
- Inhibition of p53 acetylation by INHAT subunit SET/TAF-Iβ represses p53 activity
- (2011) Ji-Young Kim et al. NUCLEIC ACIDS RESEARCH
- Essential Requirement for PP2A Inhibition by the Oncogenic Receptor c-KIT Suggests PP2A Reactivation as a Strategy to Treat c-KIT+ Cancers
- (2010) K. G. Roberts et al. CANCER RESEARCH
- Sphingosine Interaction with Acidic Leucine-rich Nuclear Phosphoprotein-32A (ANP32A) Regulates PP2A Activity and Cyclooxygenase (COX)-2 Expression in Human Endothelial Cells
- (2010) Cheryl Habrukowich et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- KIAA1524: A novel MLL translocation partner in acute myeloid leukemia
- (2010) Eva A. Coenen et al. LEUKEMIA RESEARCH
- Identification of distinct SET/TAF-Iβ domains required for core histone binding and quantitative characterisation of the interaction
- (2009) Zoe Karetsou et al. BMC BIOCHEMISTRY
- Direct interaction between the inhibitor 2 and ceramide via sphingolipid-protein binding is involved in the regulation of protein phosphatase 2A activity and signaling
- (2008) Archana Mukhopadhyay et al. FASEB JOURNAL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now